PREPARATION AND CHARACTERIZATION OF ZAFIRLUKAST- β-CYCLODEXTRIN COMPLEXES USING SOLID DISPERSION TECHNIQUES

Zafirlukast is an oral leukotriene receptor antagonist used in the treatment of asthma. Poor solubility in biological fluids is the major problem with this drug which results in poor bioavailability after an oral administration. The rate of absorption and the extent of bioavailability for such a poor soluble drug is controlled by rate of dissolution in gastrointestinal fluids. Hence an attempt has been made to enhance the solubility of the drug by preparing its complex with β-cyclodextrin. FT-IR studies were performed. Drugcomplexing agent interactions were investigated using differential scanning calorimetry(DSC) . The study clearly shows that the dissolution rate of zafirlukast may be enhanced to a great extent by solid dispersion technique using kneading method. This is due to the reason that the cyclodextrins increased the aqueous solubility of poorly soluble drug by forming inclusion complexes with their apolar molecules and functional groups.

[1]  로러 한스페터,et al.  Fast-disintegrating tablets , 2004 .

[2]  Tayade Pralhad,et al.  Comparative Study on Co-Ground Products of Rofecoxib with β-Cyclodextrin and Its Sulfobutyl Ether-7 Derivative in Solution and in the Solid State , 2004 .

[3]  C. Buccellati,et al.  Leukotriene Modifiers: Novel Therapeutic Opportunities in Asthma , 2002 .

[4]  S. Fuschillo,et al.  Leukotriene receptor antagonists in the treatment of asthma: an update , 2002, Allergy.

[5]  E. Stefánsson,et al.  Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. , 2001, International journal of pharmaceutics.

[6]  H. SEAGER,et al.  Drug‐delivery Products and the Zydis Fast‐dissolving Dosage Form * , 1998, The Journal of pharmacy and pharmacology.

[7]  V. Stella,et al.  Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. , 1996, Journal of pharmaceutical sciences.

[8]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[9]  F. Bonini,et al.  Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions , 1995 .

[10]  A. Karara,et al.  Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system , 1986 .

[11]  F. Hirayama,et al.  Improvement of dissolution characteristics and chemical stability of prostaglandin E1 by .GAMMA.-cyclodextrin complexation. , 1984 .

[12]  W. L. Chiou,et al.  Pharmaceutical applications of solid dispersion systems: dissolution of griseofulvin-succinic acid eutectic mixture. , 1976, Journal of pharmaceutical sciences.

[13]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[14]  K. Goa,et al.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma. , 2001, Drugs.

[15]  T. Loftsson Pharmaceutical applications of β-cyclodextrin , 1999 .